Asian markets have opened with modest gains on Thursday, tracking a positive close on Wall Street amid signs that the Covid-19 outbreak is easing.
Markets in Japan, South Korea and Australia are trading with modest gains in early trade.
Futures on the S&P 500 have dipped lower after the benchmark rebounded from its biggest one-day fall in three weeks.
U.S. President Donald Trump ordered to destroy any Iranian gun boats that harass American ships at sea.
🎯 Vodafone Idea :
🎯 Vodafone Idea :
Vodafone Group says that it has accelerated payment of $200 million to the company, providing liquidity to manage its operations.
Positive for the stock. 👍
🎯 Aurobindo Pharma :
Company gets US FDA nod for Pantoprazole Sodium Injectable (40 Mg).
Positive for the stock. 👍
🎯 KNR Constructions :
SPVs have re-commenced the collection of user fee (toll) on all the NHAl projects.
🎯 NBCC :
NCLAT has asked NBCC to implement its proposal to acquire debt ridden Jaypee Infratech and complete over 20,000 pending flats, but said the direction is subject to its final order.
🎯 Lupin :
Solosec oral granules have received preferred coverage effective immediately on the Express Scripts National Preferred, Flex, and Basic commercial formularies.
🎯 SpiceJet :
Two lessors to SpiceJet Ltd are in talks to terminate contracts and repossess planes via mutually agreed deals with the airline over missed payments.
🎯 Star Cement :
Plant at Assam has partially become operational.
🎯 Kirloskar Electric :
Manufacturing unit at Hubli has resumed operations.
🎯 Orient Paper and Industries : Production of tissue papers and chlorine is continuing.
🎯 Deepak Nitrite :
🎯 Deepak Nitrite :
Partially commenced operations at its Hyderabad plant. All manufacturing facilities have commenced operations now.
🎯 Sun Pharma :
Promoters released pledge of 2.52 crore shares between April 20-21.
Positive for the stock. 👍
🎯 Adani Ports & SEZ :
Promoter SB Adani Family Trust revoked pledge of 37.5 lakh shares on April 21.
Positive for the stock. 👍
✒ ✒ ✒ ✒ ✒ ✒ ✒ ✒ ✒ ✒ ✒ ✒ ✒
Edited by Sharp.
No comments:
Post a Comment